Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer.

MLA

Litvak, Anya, et al. “Racial Disparities in the Rate of Cardiotoxicity of HER2-Targeted Therapies among Women with Early Breast Cancer.” Cancer (0008543X), vol. 124, no. 9, May 2018, pp. 1904–11. EBSCOhost, https://doi.org/10.1002/cncr.31260.

APA

Litvak, A., Batukbhai, B., Russell, S. D., Tsai, H., Rosner, G. L., Jeter, S. C., Armstrong, D., Emens, L. A., Fetting, J., Wolff, A. C., Silhy, R., Stearns, V., Connolly, R. M., & Tsai, H.-L. (2018). Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer. Cancer (0008543X), 124(9), 1904–1911. https://doi.org/10.1002/cncr.31260

Chicago

Litvak, Anya, Bhavina Batukbhai, Stuart D. Russell, Hua‐Ling Tsai, Gary L. Rosner, Stacie C. Jeter, Deborah Armstrong, et al. 2018. “Racial Disparities in the Rate of Cardiotoxicity of HER2-Targeted Therapies among Women with Early Breast Cancer.” Cancer (0008543X) 124 (9): 1904–11. doi:10.1002/cncr.31260.